152 related articles for article (PubMed ID: 33497751)
1. Brigham and Women's Hospital tumor classification system for basal cell carcinoma identifies patients with risk of metastasis and death.
Morgan FC; Ruiz ES; Karia PS; Besaw RJ; Neel VA; Schmults CD
J Am Acad Dermatol; 2021 Sep; 85(3):582-587. PubMed ID: 33497751
[TBL] [Abstract][Full Text] [Related]
2. Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women's Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma.
Ruiz ES; Karia PS; Besaw R; Schmults CD
JAMA Dermatol; 2019 Jul; 155(7):819-825. PubMed ID: 30969315
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma.
Karia PS; Jambusaria-Pahlajani A; Harrington DP; Murphy GF; Qureshi AA; Schmults CD
J Clin Oncol; 2014 Feb; 32(4):327-34. PubMed ID: 24366933
[TBL] [Abstract][Full Text] [Related]
4. Stratification of Poor Outcomes for Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients Using the American Joint Committee on Cancer Eighth Edition and Brigham and Women's Hospital Staging Systems.
Blechman AB; Carucci JA; Stevenson ML
Dermatol Surg; 2019 Sep; 45(9):1117-1124. PubMed ID: 30640779
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the American Joint Committee on Cancer Seventh Edition and Brigham and Women's Hospital Cutaneous Squamous Cell Carcinoma Tumor Staging in Immunosuppressed Patients.
Gonzalez JL; Cunningham K; Silverman R; Madan E; Nguyen BM
Dermatol Surg; 2017 Jun; 43(6):784-791. PubMed ID: 28079640
[TBL] [Abstract][Full Text] [Related]
6. Comparing the eighth and the seventh editions of the American Joint Committee on Cancer staging system and the Brigham and Women's Hospital alternative staging system for cutaneous squamous cell carcinoma: Implications for clinical practice.
Cañueto J; Burguillo J; Moyano-Bueno D; Viñolas-Cuadros A; Conde-Ferreirós A; Corchete-Sánchez LA; Pérez-Losada J; Román-Curto C
J Am Acad Dermatol; 2019 Jan; 80(1):106-113.e2. PubMed ID: 30003984
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Tumor Staging: Predicting Nodal Metastases in Cutaneous Squamous Cell Carcinoma.
Upton M; Kita A; Scapa J; St John M
Laryngoscope; 2021 Jan; 131(1):E170-E175. PubMed ID: 32212346
[TBL] [Abstract][Full Text] [Related]
8. Comparison of tumor staging systems for cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia.
Inda JJ; Kabat BF; Larson MC; Slager SL; Baum CL
J Am Acad Dermatol; 2019 Mar; 80(3):639-645. PubMed ID: 30165169
[TBL] [Abstract][Full Text] [Related]
9. Validation of four cutaneous squamous cell carcinoma staging systems using nationwide data.
Venables ZC; Tokez S; Hollestein LM; Mooyaart AL; van den Bos RR; Rous B; Leigh IM; Nijsten T; Wakkee M
Br J Dermatol; 2022 May; 186(5):835-842. PubMed ID: 34862598
[TBL] [Abstract][Full Text] [Related]
10. Validating 4 Staging Systems for Cutaneous Squamous Cell Carcinoma Using Population-Based Data: A Nested Case-Control Study.
Roscher I; Falk RS; Vos L; Clausen OPF; Helsing P; Gjersvik P; Robsahm TE
JAMA Dermatol; 2018 Apr; 154(4):428-434. PubMed ID: 29516080
[TBL] [Abstract][Full Text] [Related]
11. Predictive Value of Sentinel Lymph Node Biopsy in Cutaneous Squamous Cell Carcinoma Based on the AJCC-8 and Brigham and Women's Hospital Staging Criteria.
Tejera-Vaquerizo A; Cañueto J; Llombart B; Martorell-Calatayud A; Sanmartín O
Dermatol Surg; 2020 Jul; 46(7):857-862. PubMed ID: 31567487
[TBL] [Abstract][Full Text] [Related]
12. Performance of Salamanca refinement of the T3-AJCC8 versus the Brigham and Women's Hospital and Tübingen alternative staging systems for high-risk cutaneous squamous cell carcinoma.
Puebla-Tornero L; Corchete-Sánchez LA; Conde-Ferreirós A; García-Sancha N; Corchado-Cobos R; Román-Curto C; Cañueto J
J Am Acad Dermatol; 2021 Apr; 84(4):938-945. PubMed ID: 33333151
[TBL] [Abstract][Full Text] [Related]
13. Metastatic Cutaneous Squamous Cell Carcinoma: The Importance of T2 Stratification and Hematologic Malignancy in Prognostication.
Stevenson ML; Kim R; Meehan SA; Pavlick AC; Carucci JA
Dermatol Surg; 2016 Aug; 42(8):932-5. PubMed ID: 27467226
[TBL] [Abstract][Full Text] [Related]
14. Identifying Brigham and Women's Hospital stage T2a cutaneous squamous cell carcinomas at risk of poor outcomes.
Gupta N; Weitzman RE; Murad F; Koyfman SA; Smile TD; Chang MS; Maher JM; Schmults CD; Vidimos AT; Ruiz ES
J Am Acad Dermatol; 2022 Jun; 86(6):1301-1308. PubMed ID: 34864111
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous squamous cell carcinoma staging may influence management in users: A survey study.
Patel VA; McCullum C; Sparks AD; Schmults CD; Arron ST; Jambusaria-Pahlajani A
Cancer Med; 2022 Jan; 11(1):94-103. PubMed ID: 34796670
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the eighth edition of the TNM and Brigham Women's Hospital staging systems for cutaneous squamous cell carcinoma of the head and neck: a six-year review.
Bowe CM; Houlton S; Walsh S
Br J Oral Maxillofac Surg; 2020 Nov; 58(9):1158-1163. PubMed ID: 33071049
[TBL] [Abstract][Full Text] [Related]
17. Higher metastasis and death rates in cutaneous squamous cell carcinomas with lymphovascular invasion.
Kus KJB; Murad F; Smile TD; Chang M; Ashrafzadeh S; Zhou G; Ilori EO; Koyfman SA; Vidimos AT; Schmults CD; Ruiz ES
J Am Acad Dermatol; 2022 Apr; 86(4):766-773. PubMed ID: 34774657
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system.
Jambusaria-Pahlajani A; Kanetsky PA; Karia PS; Hwang WT; Gelfand JM; Whalen FM; Elenitsas R; Xu X; Schmults CD
JAMA Dermatol; 2013 Apr; 149(4):402-10. PubMed ID: 23325457
[TBL] [Abstract][Full Text] [Related]
19. Comparative Performance of Four Staging Classifications to Select «High-Risk» Head and Neck Cutaneous Squamous Cell Carcinomas.
Elaldi R; Chamorey E; Schiappa R; Sudaka A; Anjuère F; Villarmé A; Culié D; Bozec A; Montaudié H; Poissonnet G
J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373623
[TBL] [Abstract][Full Text] [Related]
20. Detection of High-Risk Histologic Features and Tumor Upstaging of Nonmelanoma Skin Cancers on Debulk Analysis: A Quantitative Systematic Review.
Singh B; Dorelles A; Konnikov N; Nguyen BM
Dermatol Surg; 2017 Aug; 43(8):1003-1011. PubMed ID: 28654579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
